Search PubMed⌕ Search

Biomedical subjects

I Elomaa

Publications and source records attributed to I Elomaa.

140 records · Page 8Linked to original sources
PubMed1983

Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.

Thirty-four normocalcaemic women with multiple osteolytic bone metastases from breast cancer were randomly allocated to treatment with disodium dichloromethylene diphosphonate (Cl2MDP) 1600 mg/day orally (17) or placebo (17) for 3-9 months. Fasting urinary hydroxyproline/creatinine and calcium/creatinine ratios declined in the Cl2MDP group but not in the placebo group. Four patients in the placebo group died from hypercalcaemia. New bone metastases were more common in patients on placebo and these patients also required more analgesic drugs than those on Cl2MDP. Cl2MDP seemed to reduce bone pain and bone resorption and prevent the development of hypercalcaemia caused by osteolytic metastases. The formation of new bone metastases and the growth of old ones seemed to be retarded by Cl2MDP.

Adult↗
PubMed1983

Effect of dichloromethylene diphosphonate (Cl2MDP) on immune function in breast cancer patients with bone metastases.

Immune function was studied in normocalcemic breast cancer patients with bone metastases treated with either dichloromethylene diphosphonate (Cl2MDP) or placebo. The results showed no significant difference between the two patient groups. This suggests that Cl2MDP does not markedly impair the host's defense mechanisms, and in this respect can be safely used in the treatment of patients with resorptive bone disease.

Adult↗
PubMed1983

Amyloid-associated muscle pseudohypertrophy and multiple myeloma in a man with hypernephroma.

Amyloidosis is known to occur both in renal adenocarcinoma and multiple myeloma. This paper describes a 52-year-old man who developed multiple myeloma and widespread amyloidosis after surgical removal of a hypernephroma. Multiple myeloma presented with osteolytic bone lesions and slight bone marrow plasmocytosis. Both kappa light chains and monoclonal IgG were secreted. Amyloidosis was seen as muscle pseudohypertrophy with wood-hard masses of amyloid in shoulders, girdle, buttocks and proximal limbs. Macroglossia was impressive and swelling of submandibular structures and the floor of the mouth was marked. Knowing the peculiar immunological potency of hypernephroma, attention is called to associations between renal carcinoma and monoclonal gammopathies, including amyloidosis.

Adenocarcinoma↗
PubMed1982

Seasonal variation of urinary calcium and oxalate excretion, serum 25(OH)D3 and albumin level in relation to renal stone formation.

Seasonal variations in urinary calcium and oxalate excretion, serum 25(OH)D3 and albumin level were studied in 11 normo- and 11 hypercalciuric renal stone-formers, in 10 healthy subjects and in 14 long-stay hospital patients during one year. Serum albumin levels increased significantly during May--October in all four groups, whereas no significant changes occurred in serum calcium values when adjusted for differences in serum albumin concentration. Serum 25(OH)D3 level, urinary calcium and oxalate excretion were significantly higher during May--October than November--April in all except the long-stay hospital patients, whose corresponding values showed no seasonal changes and whose serum 25(OH)D3 levels as well as urinary calcium excretion were significantly lower than in the other three groups. The serum 25(OH)D3 level was significantly higher throughout the year in hypercalciuric than normocalciuric stone-formers. The hypercalciuric patients also passed more stones than the normocalciuric patients during a period of 9 years. There was a positive correlation between serum 25(OH)D3 and urinary calcium, between serum 25(OH)D3 and stone episodes and between urinary calcium and stone episodes. Because of this positive correlation, it might be useful to concentrate preventive therapy for recurrent renal stones to the light period only.

Adult↗
PubMed1979

Blood cadmium and plasma zinc measurements in acute myocardial infarction.

Blood cadmium and plasma zinc were measured in a series of 47 patients admitted for myocardial infarction (MI) and in 37 control subjects divided into 3 groups. Certainly increased blood cadmium values, for the MI patients, were found in 33%. The mean blood cadmium value of the MI series was significantly (P less than 0.001), but not invariably, higher against the control subjects. The difference between the zinc values of the series was studied in 35 MI patients with raised serum enzyme activity. In MI patients, the mean plasma zinc content was significantly (0.001 less than P less than 0.01) lower than in healthy controls. Of the enzymes, the highest positive correlation was found between the ratio of blood cadmium to plasma zinc and the GOT activity. Of the ratio, the MI patients had values in excess of the controls range in 43%, and values within the limits of the healthy controls in 40%. Therefore, the rise in the ratio is of limited value for the diagnosis of myocardial infarction in an individual patient.

Acute Disease↗
PubMedDate not supplied

Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer.

We studied bone biopsies from 65 normocalcaemic women with breast cancer and predominantly osteolytic bone metastases in order to examine the pathophysiology of bone destruction in metastatic bone disease. Quantitative histomorphometric measurements were made at sites of tumour involvement, at sites adjacent to tumour tissue and at sites distant from tumour tissue. There were no significant differences in bone volume or in indices of bone resorption or formation between biopsies taken from sites distant from tumour and the controls. Bone resorption, as judged by eroded surface, increased progressively from bone distant from tumour to tumour-laden bone. The number of osteoclasts was significantly increased in bone immediately adjacent to tumour and within metastases. There was no decrease in the ratio of osteoclast to eroded surface in breast cancer compared to controls suggesting that increased resorption in breast cancer was mainly osteoclast mediated and locally activated by the tumour. Two thirds of the biopsies taken from tumour involved regions showed osteosclerosis with woven bone formation. The volume of the pre-existing lamellar trabecular bone was lower than normal in 75% of these biopsies, suggesting that bone resorption must have been increased before the onset of woven bone formation. Since all patients were receiving hormonal treatment or chemotherapy, it is likely that osteosclerosis at sites of previous resorption mainly resulted from the basic cancer treatment as a sign of response to treatment. Osteoclastic bone resorption was, however, not completely inhibited by the active cancer treatment.

Adult↗